Cancer Research Meeting Calendar  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 700-705, February 15, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Black, A. R.
Right arrow Articles by Dolnick, B. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Black, A. R.
Right arrow Articles by Dolnick, B. J.

Expression of rTS Correlates with Altered Growth Regulation of Thymidylate Synthase1

Adrian R. Black and Bruce J. Dolnick2

Department of Experimental Therapeutics, Roswell Park Cancer Institute, Buffalo, New York 14263

The recently discovered rTS gene is convergent with and overlaps the thymidylate synthase gene in the antisense orientation. K562 B1A and KB 1BT are two methotrexate-resistant cell lines that have amplified genes for dihydrofolate reductase. K562 B1A cells have increased levels of rTS mRNA and protein compared with their parental K562 cells, whereas KB 1BT cells show unaltered rTS expression compared with their parental (KB) cells. Altered levels and loss of growth-regulation of in situ thymidylate synthase activity were found in methotrexate-resistant K562 B1A cells but not in K562, KB, and KB 1BT cells. These data point to a link between rTS and the regulation of TS activity.

1 This work was supported by USPHS Grant CA57634 from the National Cancer Institute and in part by CORE Grant CA16056.

2 To whom requests for reprints should be addressed, at Department of Experimental Therapeutics, Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. Phone: (716) 845-5828; Fax: (716) 845-8857; E-mail: dolnick@sc3103.med.buffalo.edu.

Received 11/10/95. Accepted 1/ 2/96.




This article has been cited by other articles:


Home page
Cancer Res.Home page
R. Dolnick, Q. Wu, N. J. Angelino, L. V. Stephanie, K.-C. Chow, J. R. Sufrin, and B. J. Dolnick
Enhancement of 5-Fluorouracil Sensitivity by an rTS Signaling Mimic in H630 Colon Cancer Cells
Cancer Res., July 1, 2005; 65(13): 5917 - 5924.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. W. Bateman, D. Tan, R. G. Pestell, J. D. Black, and A. R. Black
Intestinal Tumor Progression Is Associated with Altered Function of KLF5
J. Biol. Chem., March 26, 2004; 279(13): 12093 - 12101.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
Q. Wu and B. J. Dolnick
Detection of Thymidylate Synthase Modulators by a Novel Screening Assay
Mol. Pharmacol., January 1, 2003; 63(1): 167 - 173.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.